![Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App - Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App -](https://cdn2.hubspot.net/hub/2749033/hubfs/US%20Benchmark%20%26%20Global%20Indices%204%20Sep%20(1).png?upscale=true&width=1400&upscale=true&name=US%20Benchmark%20%26%20Global%20Indices%204%20Sep%20(1).png)
Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App -
![Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1642603837/teva1_1.jpg/teva1_1.jpg?VersionId=nO05_Vv2BJv9MBUgDNsNaIO1LnDj7m4Q)
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
![Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App - Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App -](https://bondevalue.com/wp-content/uploads/2020/09/shutterstock_429287551-min-scaled.jpg)
Chinese Developers Face Liquidity Test; Teva, Nordstrom, Sappi Downgraded; Macy's Q2 Earnings Beat Estimates - Track Live Bond Prices Online with BondEValue App -
![Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg](http://reorg-research.com/images/Teva+Org+Chart.png)
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
![Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports. Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.](https://data.cbonds.com/organisations_logos/13739/1506089713teva.png)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
![Israel: Teva Pharma plans US$4bn sustainability-linked notes to buy back notes due 2022 - 2024 - LaingBuisson News Israel: Teva Pharma plans US$4bn sustainability-linked notes to buy back notes due 2022 - 2024 - LaingBuisson News](https://www.laingbuissonnews.com/wp-content/uploads/sites/3/2021/09/sustainability-scaled.jpg)